Zentalis Pharmaceuticals, Inc. (ZNTL) Revenue (2024)
Zentalis Pharmaceuticals (ZNTL) posted quarterly Revenue of $26.9 million for Q4 2024, down 33.76% on a QoQ basis from $40.6 million in Q1 2024.
Zentalis Pharmaceuticals, Inc. (ZNTL) Revenue (2024) Analysis & Trends
Zentalis Pharmaceuticals (ZNTL) has reported Revenue for 1 consecutive years, with $26.9 million the latest figure, recorded in Q4 2024.
- In Q4 2024, Revenue changed N/A year-over-year to $26.9 million; the TTM figure through Sep 2025 stood at $26.9 million (down 33.76% YoY), while the FY2024 annual figure was $67.4 million, changed N/A from the prior year.
- Revenue came in at $26.9 million for Q4 2024 at Zentalis Pharmaceuticals, down from $40.6 million in the prior quarter.
- The five-year high for Revenue was $40.6 million in Q1 2024, with the low at $26.9 million in Q4 2024.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 26.87 Mn |
| Mar 31, 2024 | 40.56 Mn |